Shin Nippon Biomedical Laboratories Ltd (2395.T) released a profit for first half that Dropped, from last year
The company's bottom line totaled JPY1.061 billion, or JPY25.48 per share. This compares with JPY1.331 billion, or JPY31.97 per share, last year.
The company's revenue for the period rose 18.1% to JPY14.766 billion from JPY12.508 billion last year.
Shin Nippon Biomedical Laboratories Ltd earnings at a glance (GAAP) :
-Earnings: JPY1.061 Bln. vs. JPY1.331 Bln. last year.-EPS: JPY25.48 vs. JPY31.97 last year.-Revenue: JPY14.766 Bln vs. JPY12.508 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.